Myocardial viability evaluation using magnetocardiography in patients with coronary artery disease

Coronary Artery Disease

Volumn 15, Issue 3, 2004, Pages 155-162

  Morguet, Andreas J ^a   Behrens, Steffen ^a   Kosch, Olaf ^b   Lange, Christine ^a   Zabel, Markus ^a   Selbig, Daniela ^c   Munz, Dieter L ^a   Schultheiss, Heinz Peter ^a   Koch, Hans ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Phys Technische Bundesanstalt ^*  (Germany)

^c Franz Volhard Klinik   (Germany)

Author keywords

Coronary artery disease; Fluorodeoxyglucose; Magnetocardiography; Myocardial viability; Positron emission tomography; SQUID

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM CHLORIDE TL 201;

ACCURACY; ADULT; AGED; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DEVICE; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FISHER EXACT TEST; HEART INFARCTION; HEART MUSCLE; HUMAN; LINEAR SYSTEM; LOW TEMPERATURE; MAGNETOCARDIOGRAPHY; MALE; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE; SUPERCONDUCTOR; TECHNIQUE;

ADULT; AGED; CICATRIX; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETICS; MALE; MIDDLE AGED; MYOCARDIUM; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; THALLIUM; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2342538381     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200405000-00004     Document Type: Article

References (28)

1. Koch H, Haberkorn W. Magnetic field mapping of cardiac electrophysiological function. Phil Trans R Soc Lond A 2001; 359: 1287-1298.
2. Mäkijärvi M. Recording of abnormal late ventricular activity by high-resolution magnetocardiography. Int J Card Imaging 1991; 7:237-241.
3. Endt P, Montonen J, Mäkijärvi M, Nenonen J, Steinhoff U, Trahms L, et al. Identification of post-myocardial infarction patients with ventricular tachycardia by time-domain intra-QRS analysis of signal-averaged electrocardiogram and magnetocardiogram. Med Biol Eng Comput 2000; 38:659-666.
4. Link A, Trahms L, Oeff M. Regularity assessment of high frequency components in magneto/electrocardiograms of healthy subjects and risk patients. IEEE Comput Cardiol 1996; 22:493-496.
5. Schmitz L, Czerski K, Brockmeier K, Agrawal R, Steinhoff U, Trahms L, et al. Magnetocardiographic turbulence analysis in patients with long QT syndrome. J Electrocardiol 1998; 30:106-113.
6. Hombach V, Kochs M, Weismüller P, Clausen M, Henze E, Richter P, et al. Localization of ectopic ventricular depolarization by ISPECT-radionuclide ventriculography and by magnetocardiography. ISPECT and MCG for ectopic mapping. Int J Card Imaging 1991; 7:226-235.
7. Müller HP, Gödde P, Czerski K, Agrawal R, Feilcke G, Reither K, et al. Localization of a ventricular tachycardia-focus with multichannel magnetocardiography and three-dimensional current density reconstruction. Med Eng Technol 1999; 23:108-116.
8. Agren PL, Goranson H, Jonsson H, Bergfeldt L. Magnetocardiographic and magnetic resonance imaging for noninvasive localization of ventricular arrhythmia origin in a model of nonischemic cardiomyopathy. Pacing Clin Electrophysiol 2002; 25:161-166.
9. Weism̈ller P, Abraham-Fuchs K, Schneider S, Richter P, Kochs M, Hombach V. Magnetocardiographic non-invasive localization of accessory pathways in the Wolff-Parkinson-White syndrome by a multichannel system. Eur Heart J 1992; 13:616-622.
10. Hukkinen K, Kariniemi V, Katila TE, Laine H, Lukander R, Makipaa P. Instantaneous fetal heart rate monitoring by electromagnetic methods. Am J Obstet Gynecol 1976; 125:1116-1120.
11. Horigome H, Takahashi MI, Asaka M, Shigemitsu S, Kandori A, Tsukada K. Magnetocardiographic determination of the developmental changes in PQ, QRS and QT intervals in the foetus. Acta Paediatr 2000; 89:64-67.
12. Anastasiadis PG, Anninos P, Kotini A, Koutlaki N, Garas A, Galazios G. Neonatal magnetocardiography. Clin Exp Obstet Gynecol 2001; 28:267-260.
13. Kahler C, Grimm B, Schleussner E, Schneider A, Schneider U, Nowak H, et al. The application of fetal magnetocardiography (FMCG) to investigate fetal arrhythmias and congenital heart defects (CHD). Prenat Diagn 2001; 21:176-182.
14. Brockmeier K, Schmitz L, de Jesus Bobadilla Chavez J, Burghoff M, Koch H, Zimmermann R, et al. Magnetocardiography and 32-lead potential mapping. J Cardiovasc Eloctrophys 1997; 8:616-626.
15. Hänninen H, Takala P, Mäkijärvi M, Montonen J, Korhonen P, Oikarinen L, et al. Detection of exercise-induced myocardial ischemia by multichannel magnetocardiography in single-vessel coronary artery disease. Ann Noninvasive Electrocardiol 2000; 5:147-157.
16. Hänninen H, Takala P, Mäkijärvi M, Montonen J, Korhonen P, Oikarinen L, et al. Recording locations in multichannel magnetocardiography and body surface potential mapping sensitive for regional exercise-induced myocardial ischemia. Bas Res Cardiol 2001; 96:405-414.
17. Hänninen H, Takala P, Korhonen P, Oikarinen L, Mäkijärvi M, Nenonen J, et al. Features of ST segment and T-wave in exercise-induced myocardial ischemia evaluated with multichannel magnetocardiography. Ann Med 2002; 34:120-129.
18. Schiller NB, Shah PH, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two- dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
19. Drung D. The PTB 83-SQUID system for biomagnetic applications in a clinic. IEEE Trans Appl Supercond 1995; 5:2112-2116.
20. Thrombolysis in Myocardial Infarction (TIMI) Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med 1985; 312:932-936.
21. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141-146.
22. Kiat H, Berman DS, Maddahi J, De Yang L, Van Train K, Rozanski A, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988; 12:1456-1463.
23. 201TI single-photon emission computed tomography. Circulation 1995; 91:2748-2752.
24. Hoffmann R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996; 27:330-336.
25. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67:766-778.
26. Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER, et al. Predictive value of low-dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996; 28:60-69.
27. Leder U, Schrey F, Haueisen J, Dorrer L, Schreiber J, Liehr M, et al. Reproducibility of HTS-SQUID magnetocardiography in an unshielded clinical environment. Int J Cardiol 2001; 79:237-243.
28. Alderman EL, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigation Study (BARI). Coron Artery Dis 1992; 3:1189-1207.